Mexico Decentralizes Health Services

15 September 1996

Mexico has begun to shift the provision of health care from central government to its 31 states. 13 billion pesos ($1.72 billion) of federal funds is being transferred to the states on a pro rata basis, with 6 billion pesos to be used for health care provision to year-end, and the rest used for building and modernizing Ministry of Health hospitals, clinics and health centers.

President Ernesto Zedillo Ponce de Leon said decentralization will produce "a more flexible structure sensitive to local problems, (and) able to combat local supply shortages and general health problems effectively." There will be less duplication, and clinics will be able to specialize and provide more efficient care to more people. The work of over 103,000 health care staff will now be coordinated by 31 state health directors, and there are also plans for 5,000 extra medical staff.

Health Minister Juan Ramon de la Fuentes denied that states which are now in economic difficulties will be unable to weather the change and operate their own health systems. "Difficult times are often the best opportunity to produce change, assuming each state takes advantage of the fresh influx of federal funds," he said, adding that each state will be empowered "to make its own advances in health care."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight